Study for people with Heart Disease

Recruiting Not a phased study

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Not a phased study
Sponsor Edwards Lifesciences
Registry number NCT04889872
Started 12 October 2021 Today 16 October 2026 Estimated completion 1 June 2029

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
The Prince Charles Hospital Chermside QLD Active not recruiting
Royal Adelaide Hospital Adelaide SA Active not recruiting
Flinders Medical Centre Bedford Park SA Active not recruiting
Monash Health Clayton VIC Active not recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 65 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 2250

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Key Inclusion Criteria:

1. 65 years of age or older at time of randomization

2. Moderate aortic stenosis

3. Subject has symptoms or evidence of cardiac damage/dysfunction

4. The subject or subject's legal representative has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent.

Key Exclusion Criteria:

1. Native aortic annulus size unsuitable for the THV

2. Anatomical characteristics that would preclude safe transfemoral placement of the introducer sheath or safe passage of the delivery system

3. Aortic valve is unicuspid or non-calcified

4. Bicuspid aortic valve with an aneurysmal ascending aorta \> 4.5 cm or severe raphe/leaflet calcification

5. Pre-existing mechanical or bioprosthetic aortic valve

6. Severe aortic regurgitation

7. Prior balloon aortic valvuloplasty to treat severe AS

8. LVEF \< 20%

9. Left ventricular outflow tract calcification that would increase the risk of annular rupture or significant paravalvular leak post-TAVR

10. Cardiac imaging evidence of intracardiac mass, thrombus, or vegetation

11. Coronary or aortic valve anatomy that increases the risk of coronary artery obstruction post-TAVR

Dates on the record

Started 12 October 2021
Estimated completion 1 June 2029
Registry last updated 17 December 2025
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 17 December 2025.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.